|
| ||
Douglas Pharmaceuticals to remain in family ownership |
||
MEDIA RELEASE - November 30, 2012
Douglas Pharmaceuticals to remain in family ownership
Auckland, New Zealand November 30, 2012: New Zealand’s largest pharmaceutical manufacturer is to remain in family ownership.
The company had received a number of purchase offers over the years and recently decided to formalise the process through an Information Memorandum (IM) to prospective purchasers via its advisors Deutsche Bank.
After receiving the offers, Douglas Pharmaceuticals’ founder and managing director, Sir Graeme Douglas considers the best way forward for the company is to retain its private ownership. The company will bolster its export activities through the addition of experienced and qualified executives with emphasis on emerging markets in Asia and Latin America.
“Along with my Board, I remain committed and passionate about the future of our New Zealand-manufactured pharmaceuticals enjoying ever-increasing success in the world markets.”
Founded
in 1967 by Sir Graeme Douglas, the company employs 460
people marketing and distributing its product domestically,
and exporting to a further 45 countries worldwide, including
recent launches in the USA.
ends
Company Fails To Provide Records: Initial Action Over $4-An-Hour Wage Claims
Greens: Fonterra To Avoid Drilling-Waste Farms
Beer: Tuatara Set To Grow With New Investor
Stat! New Statistics NZ Chief Executive Appointed
PC Magazines Gone. Mad? Fairfax Magazines Resign Technology Title Licences
Scoop Business: Mediaworks Receivership - New Ownership Planned
Scoop Business: NZ Consumer Confidence Jumps To 3-Year High In June

